The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2025
Synopsis
The global Gastroesophageal Reflux Disease Therapeutics market was valued at US$ 4801.8 million in 2023 and is anticipated to reach US$ 4286.6 million by 2030, witnessing a CAGR of -1.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease Therapeutics.
Report Scope
The Gastroesophageal Reflux Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroesophageal Reflux Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroesophageal Reflux Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Eisai
Takeda Pharmaceutical
GlaxoSmithKline
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Segment by Type
Antacids
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Pro-kinetic Agents
Others
Segment by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Gastroesophageal Reflux Disease Therapeutics market was valued at US$ 4801.8 million in 2023 and is anticipated to reach US$ 4286.6 million by 2030, witnessing a CAGR of -1.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Disease Therapeutics.
Report Scope
The Gastroesophageal Reflux Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroesophageal Reflux Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroesophageal Reflux Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Eisai
Takeda Pharmaceutical
GlaxoSmithKline
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
Segment by Type
Antacids
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
Pro-kinetic Agents
Others
Segment by Application
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastroesophageal Reflux Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antacids
1.2.3 H2 Receptor Blockers
1.2.4 Proton Pump Inhibitors (PPIs)
1.2.5 Pro-kinetic Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Drug Stores
1.3.4 General Stores
1.3.5 Supermarkets
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2019-2030)
2.2 Gastroesophageal Reflux Disease Therapeutics Growth Trends by Region
2.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Gastroesophageal Reflux Disease Therapeutics Market Dynamics
2.3.1 Gastroesophageal Reflux Disease Therapeutics Industry Trends
2.3.2 Gastroesophageal Reflux Disease Therapeutics Market Drivers
2.3.3 Gastroesophageal Reflux Disease Therapeutics Market Challenges
2.3.4 Gastroesophageal Reflux Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue
3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2023
3.5 Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Type
4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application
5.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2019-2030)
6.2 North America Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2019-2030)
7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Detail
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Detail
11.6.2 Daewoong Pharmaceutical Business Overview
11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Detail
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
11.7.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antacids
Table 3. Key Players of H2 Receptor Blockers
Table 4. Key Players of Proton Pump Inhibitors (PPIs)
Table 5. Key Players of Pro-kinetic Agents
Table 6. Key Players of Others
Table 7. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2019-2024)
Table 11. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2025-2030)
Table 13. Gastroesophageal Reflux Disease Therapeutics Market Trends
Table 14. Gastroesophageal Reflux Disease Therapeutics Market Drivers
Table 15. Gastroesophageal Reflux Disease Therapeutics Market Challenges
Table 16. Gastroesophageal Reflux Disease Therapeutics Market Restraints
Table 17. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2023)
Table 20. Ranking of Global Top Gastroesophageal Reflux Disease Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. AstraZeneca Company Detail
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product
Table 52. AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Eisai Company Detail
Table 55. Eisai Business Overview
Table 56. Eisai Gastroesophageal Reflux Disease Therapeutics Product
Table 57. Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Eisai Recent Development
Table 59. Takeda Pharmaceutical Company Detail
Table 60. Takeda Pharmaceutical Business Overview
Table 61. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product
Table 62. Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Takeda Pharmaceutical Recent Development
Table 64. GlaxoSmithKline Company Detail
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product
Table 67. GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product
Table 72. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Daewoong Pharmaceutical Company Detail
Table 75. Daewoong Pharmaceutical Business Overview
Table 76. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product
Table 77. Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Daewoong Pharmaceutical Recent Development
Table 79. Ironwood Pharmaceuticals Company Detail
Table 80. Ironwood Pharmaceuticals Business Overview
Table 81. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product
Table 82. Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Ironwood Pharmaceuticals Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Antacids Features
Figure 4. H2 Receptor Blockers Features
Figure 5. Proton Pump Inhibitors (PPIs) Features
Figure 6. Pro-kinetic Agents Features
Figure 7. Others Features
Figure 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Drug Stores Case Studies
Figure 12. General Stores Case Studies
Figure 13. Supermarkets Case Studies
Figure 14. Gastroesophageal Reflux Disease Therapeutics Report Years Considered
Figure 15. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Region: 2023 VS 2030
Figure 18. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players in 2023
Figure 19. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue in 2023
Figure 21. North America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2019-2030)
Figure 23. United States Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2019-2030)
Figure 35. China Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2019-2030)
Figure 43. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2019-2030)
Figure 47. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 50. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 51. Takeda Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 53. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 54. Daewoong Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 55. Ironwood Pharmaceuticals Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
